From GlobeNewswire: 2025-04-26 08:10:00

The Next-Generation Sequencing (NGS) Data Analysis Market is projected to grow from USD 791.07 million in 2023 to USD 4,211.15 million by 2032, with a CAGR of 19.93%. Factors driving market growth include personalized healthcare demand, decreasing sequencing costs, and expanding genomic research programs. Advances in computational biology and AI-based bioinformatics tools support faster and more accurate NGS data analysis.

In the United States, the NGS Data Analysis Market was valued at USD 290.15 million in 2023 and is expected to reach USD 1,509.44 million by 2032, with a CAGR of 19.63%. Strong healthcare infrastructure, government support for genomics research, and programs like the NIH’s All of Us Research Program contribute to the market’s growth.

Key players in the NGS Data Analysis Market include Illumina, Thermo Fisher Scientific, Qiagen, and Agilent Technologies. These companies provide services like quality control, alignment, variant calling, and annotation, catering to the increasing demand for data analysis outsourcing in clinical labs and biotech companies.

Short-read sequencing technologies, such as those offered by Illumina, dominated 70% of the NGS market in 2023 due to their accuracy, low cost, and acceptance in clinical and academic research. Academic research held 52% of the market share, driven by demand for robust analysis tools and government funding for genomic research.

North America led the NGS Data Analysis Market in 2023, with a 48% revenue share. The region’s dominance is attributed to its strong healthcare infrastructure, government support for genomics research, and presence of leading genomic companies and academic institutions driving market growth. Advanced bioinformatics research in the United States is supported by strong financing from institutions like NIH and NSF, as well as genetic giants like Illumina, Thermo Fisher Scientific, and Agilent Technologies.

Asia-Pacific is poised for rapid growth in genomic infrastructure, driven by investments, national genome sequencing projects, and government initiatives like GenomeAsia 100K and India’s Genomics for Public Health Initiative. China’s biotech drive and the rise of companies like BGI Genomics are shaping the region’s future in the sector.

Recent developments include Illumina launching Dragena 4.0, a cloud-compatible analysis tool, and Qiagen partnering with Genomics England for NGS data processing in cancer research.

SNS Insider is a leading market research agency offering valuable insights for clients worldwide, aiming to provide up-to-date market data to make informed decisions confidently.



Read more at GlobeNewswire: Next-Generation Sequencing (NGS) Data Analysis Market to